Author: Alan Condon

Smith+Nephew has launched its Cori surgical system for total and partial knee replacements in the U.K.

Johnson & Johnson on Nov. 12 announced its plan to split into two separate companies — one focusing on medical devices and drugs, and the other focusing on consumer health products.

The first artificial disc replacement in the U.S. was performed in 2000, but the technology has come a long way since then, with many surgeons predicting the procedure eventually will overtake spinal fusion as the standard of care.

Robots have transformed many industries, but will they revolutionize healthcare the way some medical device companies and surgeons say they will?

The FDA's Breakthrough Devices Program is designed to accelerate the development, assessment and review of medical devices that provide effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.

The American Association of Neurological Surgeons and the Congress of Neurological Surgeons on Nov. 19 endorsed a bill that aims to mitigate the 9.75 percent Medicare reimbursement cut facing physicians in 2022.

Maintaining independence is among the biggest challenges facing orthopedic groups amid significant industry consolidation, but migrating more higher-acuity cases to the outpatient setting and expanding ambulatory strategies represent key growth opportunities.

Ed Hellman, MD, president and interim CEO of Indianapolis-based OrthoIndy, has navigated several healthcare challenges over the last 30 years as an orthopedic surgeon.

Orthobiologics company Bioventus has signed a lease agreement to double its current operations and manufacturing space in Cordova, Tenn.

A growing number of patients are using online platforms such as Facebook, LinkedIn and Youtube to seek out healthcare providers, which presents a key opportunity for surgeons to expand their patient base.